| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies
|
Aide, Nicolas
|
|
2017
|
44 |
supplement-1 |
p. 17-31
|
artikel
|
| 2 |
Evaluating tumor response with FDG PET: updates on PERCIST, comparison with EORTC criteria and clues to future developments
|
Pinker, Katja
|
|
2017
|
44 |
supplement-1 |
p. 55-66
|
artikel
|
| 3 |
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
|
Barrington, Sally F.
|
|
2017
|
44 |
supplement-1 |
p. 97-110
|
artikel
|
| 4 |
Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician
|
Lheureux, S.
|
|
2017
|
44 |
supplement-1 |
p. 41-54
|
artikel
|
| 5 |
Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET
|
Vos, Charlotte S. van der
|
|
2017
|
44 |
supplement-1 |
p. 4-16
|
artikel
|
| 6 |
The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and Immunotherapy
|
Wong, Annie N. M.
|
|
2017
|
44 |
supplement-1 |
p. 67-77
|
artikel
|
| 7 |
Therapy assessment in multiple myeloma with PET
|
Nanni, Cristina
|
|
2017
|
44 |
supplement-1 |
p. 111-117
|
artikel
|
| 8 |
Therapy assessment in prostate cancer using choline and PSMA PET/CT
|
Ceci, Francesco
|
|
2017
|
44 |
supplement-1 |
p. 78-83
|
artikel
|
| 9 |
Therapy assessment of bone metastatic disease in the era of 223radium
|
Etchebehere, Elba
|
|
2017
|
44 |
supplement-1 |
p. 84-96
|
artikel
|
| 10 |
Therapy monitoring with PET in cancer patients: achievements, opportunities and challenges ahead for the PET community
|
Aide, Nicolas
|
|
2017
|
44 |
supplement-1 |
p. 1-3
|
artikel
|
| 11 |
Using PET for therapy monitoring in oncological clinical trials: challenges ahead
|
Deroose, C. M.
|
|
2017
|
44 |
supplement-1 |
p. 32-40
|
artikel
|
Tijdschrift beschrijving